Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.
3.

Antagonist effect of insulin-like growth factor I on protein kinase inhibitor-mediated apoptosis in human glioblastoma cells in association with bcl-2 and bcl-xL.

Toms SA, Hercbergs A, Liu J, Kondo S, Haqqi T, Casey G, Iwasaki K, Barnett GH, Barna BP.

J Neurosurg. 1998 May;88(5):884-9.

PMID:
9576258
4.

Inhibition of the glioblastoma cell cycle by type I IFNs occurs at both the G1 and S phases and correlates with the upregulation of p21(WAF1/CIP1).

Tanabe T, Kominsky SL, Subramaniam PS, Johnson HM, Torres BA.

J Neurooncol. 2000 Jul;48(3):225-32.

PMID:
11100820
5.

Honokiol exerts an anticancer effect in T98G human glioblastoma cells through the induction of apoptosis and the regulation of adhesion molecules.

Jeong JJ, Lee JH, Chang KC, Kim HJ.

Int J Oncol. 2012 Oct;41(4):1358-64. doi: 10.3892/ijo.2012.1582.

PMID:
22895699
6.

Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway.

Eom KS, Hong JM, Youn MJ, So HS, Park R, Kim JM, Kim TY.

Biol Pharm Bull. 2008 Apr;31(4):558-62.

7.

Growth inhibition of insulin-like growth factor I receptor monoclonal antibody to human colorectal cancer cells.

Zhang Y, Zhang Y.

Cancer Invest. 2008 Apr-May;26(3):230-6. doi: 10.1080/07357900701508975.

PMID:
18317963
8.

Saponin 1 induces apoptosis and suppresses NF-κB-mediated survival signaling in glioblastoma multiforme (GBM).

Li J, Tang H, Zhang Y, Tang C, Li B, Wang Y, Gao Z, Luo P, Yin A, Wang X, Cheng G, Fei Z.

PLoS One. 2013 Nov 21;8(11):e81258. doi: 10.1371/journal.pone.0081258. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/0c3019ff-6d7b-444b-8eb5-9461f3dcd029.

9.

Abnormal expression of insulin-like growth factor-I receptor in hepatoma tissue and its inhibition to promote apoptosis of tumor cells.

Dong Z, Yao M, Wang L, Yan X, Gu X, Shi Y, Yao N, Qiu L, Wu W, Yao D.

Tumour Biol. 2013 Dec;34(6):3397-405.

PMID:
23797814
10.
11.

Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression.

Chen MY, Clark AJ, Chan DC, Ware JL, Holt SE, Chidambaram A, Fillmore HL, Broaddus WC.

J Neurooncol. 2011 May;103(1):87-102. doi: 10.1007/s11060-010-0374-7.

12.

The Jak2 small molecule inhibitor, G6, reduces the tumorigenic potential of T98G glioblastoma cells in vitro and in vivo.

Baskin R, Park SO, Keserű GM, Bisht KS, Wamsley HL, Sayeski PP.

PLoS One. 2014 Aug 27;9(8):e105568. doi: 10.1371/journal.pone.0105568.

13.

Insulin-like growth factor receptor-1 as an anti-cancer target: blocking transformation and inducing apoptosis.

Wang Y, Sun Y.

Curr Cancer Drug Targets. 2002 Sep;2(3):191-207. Review.

PMID:
12188907
14.

Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor.

Ambrose D, Resnicoff M, Coppola D, Sell C, Miura M, Jameson S, Baserga R, Rubin R.

J Cell Physiol. 1994 Apr;159(1):92-100.

PMID:
8138595
15.

Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.

Schlenska-Lange A, Knüpfer H, Lange TJ, Kiess W, Knüpfer M.

Anticancer Res. 2008 Mar-Apr;28(2A):1055-60. Erratum in: Anticancer Res. 2008 May-Jun;28(3b):1965.

16.

Down-regulation of IGF-1R expression inhibits growth and enhances chemosensitivity of endometrial carcinoma in vitro.

Shu S, Yang Y, Li X, Li T, Zhang Y, Xu C, Liang C, Wang X.

Mol Cell Biochem. 2011 Jul;353(1-2):225-33. doi: 10.1007/s11010-011-0790-9.

PMID:
21442237
17.

Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinase.

Sabbatini P, Rowand JL, Groy A, Korenchuk S, Liu Q, Atkins C, Dumble M, Yang J, Anderson K, Wilson BJ, Emmitte KA, Rabindran SK, Kumar R.

Clin Cancer Res. 2009 May 1;15(9):3058-67. doi: 10.1158/1078-0432.CCR-08-2530.

18.

1-Oxoeudesm-11(13)-eno-12,8a-lactone induces G2/M arrest and apoptosis of human glioblastoma cells in vitro.

Liu SS, Wang YF, Ma LS, Zheng BB, Li L, Xie WD, Li X.

Acta Pharmacol Sin. 2013 Feb;34(2):271-81. doi: 10.1038/aps.2012.137.

19.

Structure-activity relationships of alkylphosphocholine derivatives: antineoplastic action on brain tumor cell lines in vitro.

Jendrossek V, Hammersen K, Erdlenbruch B, Kugler W, Krügener R, Eibl H, Lakomek M.

Cancer Chemother Pharmacol. 2002 Jul;50(1):71-9.

PMID:
12111115
20.

Inhibition of IGF-IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib-resistant chronic myeloid leukaemia cells.

Shi P, Chandra J, Sun X, Gergely M, Cortes JE, Garcia-Manero G, Arlinghaus RB, Lai R, Amin HM.

J Cell Mol Med. 2010 Jun;14(6B):1777-92. doi: 10.1111/j.1582-4934.2009.00795.x.

Items per page

Supplemental Content

Support Center